Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Parallel, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis On A Stable Background Of Methotrexate

NCT01008852 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01008852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01008852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Parallel, Double-Blind, Placebo-Controlled Trial To Evaluate The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis On A Stable Background Of Methotrexate
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
July 31, 2013
Enrollment
210 (actual)
Sites
55

Conditions

As the registry lists them; a condition with its own page is linked.

active rheumatoid arthritis